Please ensure Javascript is enabled for purposes of website accessibility

Italy Medical Pot Sales Rise Almost 50% to New Record in 2019

By Eric Volkman – Apr 11, 2020 at 8:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The country is one of the few European nations that has legalized medical cannabis.

Similar to the dynamic seen in many U.S. states and Canadian provinces, Italy bought significantly more cannabis in 2019 than in the previous year. Citing official government statistics, Marijuana Business Daily reported that the volume of cannabis sold in the country rose almost 50%.

All told, Italians purchased 861 kilos of medical marijuana during the year, well up from the 578 kilos of 2018. Italy is one of the few European countries that has legalized the medical form of the drug; recreational cannabis remains illegal.

Italian flags hanging in a crowded street.

Image source: Getty Images.

That amount makes Italy the No. 2 consumer of licensed medical marijuana in Europe, second only to Germany. The latter's government recently admitted that it did not know how much product its citizens purchased in 2019, although one reliable number -- the 6,714 kilos it important during the year -- shows it's clearly the leader.

Both Italy and Germany legalized medical marijuana in the 2010s. Italy did so in 2013, and Germany turned on the green light in 2017.

In Italy, most cannabis sold is exported by the Dutch Office of Medical Cannabis and grown by that country's only commercial cultivator, Bedrocan. A small amount of Italian marijuana is grown domestically by an arm of the Ministry of Defense.

The only publicly traded North American marijuana company involved in Italy is Aurora Cannabis (ACB 7.44%), which began shipping a modest amount of product there in 2018, and the following year won a tender to provide 400 kilos over a two-year stretch. Aurora is also active on the German market, although it temporarily had its license suspended late last year.

On Thursday, Aurora's share price rose by 2.8%, exceeding the gains of the key stock market indexes on the day.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.30 (7.44%) $0.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.